Russia’s Sputnik V vaccine, which still hasn’t been approved in the EU, has nevertheless seemingly won the favor of people in Germany, Switzerland and Austria, beating the already available AstraZeneca jab, a study shows.
The Russian jab which is still unavailable to most EU nations, except for Hungary, has been rated almost twice as positively as the AstraZeneca vaccine by people living in three German-speaking countries, an extensive study conducted by the Austrian Institute for Management and Economic Research (IMVF) found.
Continue reading https://on.rt.com/b33o